119 related articles for article (PubMed ID: 21122378)
1. [Killing effect of interleukin-18-enhanced FasL-expressing colon cancer cells on human hepatocytes in vitro].
Xu T; Hao XS; Ren XB; Zhang HL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):659-62. PubMed ID: 21122378
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
Xu T; Sun BC; Li Q; Hao XS
World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
[TBL] [Abstract][Full Text] [Related]
3. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
Lamy V; Roussi S; Chaabi M; Gossé F; Schall N; Lobstein A; Raul F
Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
7. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
[TBL] [Abstract][Full Text] [Related]
8. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion.
Yoong KF; Afford SC; Randhawa S; Hubscher SG; Adams DH
Am J Pathol; 1999 Mar; 154(3):693-703. PubMed ID: 10079247
[TBL] [Abstract][Full Text] [Related]
9. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
Tillman DM; Petak I; Houghton JA
Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
[TBL] [Abstract][Full Text] [Related]
10. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
[TBL] [Abstract][Full Text] [Related]
11. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.
Li H; Fan X; Stoicov C; Liu JH; Zubair S; Tsai E; Ste Marie R; Wang TC; Lyle S; Kurt-Jones E; Houghton J
Gastroenterology; 2009 Sep; 137(3):934-44, 944.e1-4. PubMed ID: 19524576
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
13. [Apoptosis of lymphocytes induced by Fas/FasL of colon cancer cells].
Zhu Q; Deng CS
Ai Zheng; 2002 Mar; 21(3):272-5. PubMed ID: 12451993
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.
Bergmann-Leitner ES; Abrams SI
Cell Immunol; 2001 Apr; 209(1):49-62. PubMed ID: 11414736
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
[TBL] [Abstract][Full Text] [Related]
16. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
[TBL] [Abstract][Full Text] [Related]
17. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.
Houston A; Waldron-Lynch FD; Bennett MW; Roche D; O'Sullivan GC; Shanahan F; O'Connell J
Int J Cancer; 2003 Nov; 107(2):209-14. PubMed ID: 12949796
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.
Chen SX; Du SY; Wang YT; Zhao HC; Zhang YL; Yao L
Tumour Biol; 2016 Jan; 37(1):323-9. PubMed ID: 26211005
[TBL] [Abstract][Full Text] [Related]
19. Fas-mediated induction of hepatocyte apoptosis in a neuroblastoma and hepatocyte coculture model.
Chen MK; Strande LF; Beierle EA; Kain MS; Geldziler BD; Doolin EJ
J Surg Res; 1999 Jun; 84(1):82-7. PubMed ID: 10334894
[TBL] [Abstract][Full Text] [Related]
20. [The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer].
Zhu Q; Deng C
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):378-80. PubMed ID: 12137598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
